This inventor holds 1 USPTO granted patent. Top assignee: Credia Japan Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Inventor Spotlight: Fumihiko Kitagawa
Introduction
Fumihiko Kitagawa, a talented inventor based in Aichi, Japan, has contributed significantly to the field of biochemistry. With a focus on innovative compounds, Kitagawa holds a patent that exemplifies his expertise and dedication to advancing scientific knowledge.
Latest Patents
Kitagawa holds a patent for a "Functional peptide nucleic acid monomer and process for producing the same." This patent describes a compound represented by a specific general formula, where A is defined within the specifications and B indicates a variable, with n being an integer ranging from 1 to 4. The process for producing this compound involves a reaction between an activated ester and t-butoxycarbonylaminoethylamine or an ω-amino acid derivative. His innovative work in this area highlights the potential applications of peptide nucleic acids in various biotechnological fields.
Career Highlights
Fumihiko Kitagawa has built his career at Credia Japan Co., Ltd., a company recognized for its contributions to scientific research and development. His innovative spirit and technical skills have allowed him to make strides in the production of functional nucleic acid monomers, paving the way for advancements in genetic research and synthetic biology.
Collaborations
Throughout his career, Kitagawa has collaborated with notable colleagues, including Hisafumi Ikeda and Isao Saito. These partnerships enhance his innovative efforts and foster an environment of creativity at Credia Japan Co., Ltd., where collaborative research often leads to groundbreaking discoveries.
Conclusion
Fumihiko Kitagawa exemplifies the spirit of innovation in the realm of scientific research. His patent on functional peptide nucleic acid monomers demonstrates his commitment to pushing the boundaries of biochemistry. With collaborations alongside talented coworkers and his role at Credia Japan Co., Ltd., Kitagawa continues to contribute to the evolution of science and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile